S. Ramanathan

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

Edwin DeJesus, Jürgen K. Rockstroh, Keith Henry et al. · The Lancet · 2012 · 346 citations

Hiv/aids Counselling, Treatment And Prevention, Medicine +12

A Randomized, Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Coformulated Emtricitabine and Tenofovir DF for Initial Treatment of HIV-1 Infection

Jürgen K. Rockstroh, Edwin DeJesus, Keith Henry et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2013 · 124 citations

Week 48, Pharmacotherapy, Antiviral Drug +18

Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection

Calvin Cohen, Richard Elion, Peter Ruane et al. · AIDS · 2011 · 109 citations

Piper betle and its bioactive metabolite phytol mitigates quorum sensing mediated virulence factors and biofilm of nosocomial pathogen Serratia marcescens in vitro

S. Ramanathan, Kannan Rama Devi, Arunachalam Kannappan et al. · Journal of Ethnopharmacology · 2016 · 101 citations

Plant-pathogen Interaction, Nosocomial Pathogen Serratia, Virulence Factor +8

Antibiofilm activity of Vetiveria zizanioides root extract against methicillin-resistant Staphylococcus aureus

Arunachalam Kannappan, Shanmugaraj Gowrishankar, S. Ramanathan et al. · Microbial Pathogenesis · 2017 · 81 citations

Methicillin-resistant Staphylococcus Aureus, Antimicrobial Susceptibility, Antibiotics +10